Browse by Medical Category
To spark collaborations at Massachusetts General Hospital that will accelerate innovation from all fields of medicine, genetics, bioengineering, and population science to build, test, and apply new technologies for early cancer detection.
The Massachusetts General Hospital Cancer Center established the Center for Innovation in Early Cancer Detection (CIECD) to increase the development of new cancer-detecting technologies. By bringing together dedicated scientists and clinicians from Mass General, Harvard Medical School and the entire Boston biomedical community, the center seeks to pair cancer detection technologies with clinical resources – with the goal of improving early cancer detection and treatment, leading to increased cures for patients around the world.
Most cancers are detected after people experience symptoms that cause them to seek medical evaluation. This often means that cancers are diagnosed when they are locally invasive or already metastatic, and no longer treatable with simple surgery or radiation treatment. Current strategies for cancer screening are limited both by their lack of sensitivity and specificity. As applied to very early cancers, which are most likely to be curable, there is an urgent need to distinguish between invasive and less invasive lesions, to avoid overtreatment and its associated risks and costs.
Under the direction of Lecia V. Sequist, MD, MPH, and with support from Mass General Cancer Center Director Daniel A. Haber, MD, PhD, the CIECD will cultivate collaboration across disciplines and lead to new avenues of innovation. Through a strong infrastructure that will include expert leadership from diverse fields, dedicated research staff, and shared resources and databases, the CIECD will increase efficiency in both early pilot work and subsequent large-scale clinical trials, speeding the delivery of new cancer diagnosis technologies.
We now stand to transform cancer screening and diagnostics with new technologies, moving away from relying on traditional radiology imaging and blood protein markers, toward molecular blood-based signatures that could potentially be more sensitive and reliable as diagnostic options.
The Mass General Cancer Center is uniquely positioned to lead a major effort in developing innovative diagnostics for early cancer detection. We will leverage several distinct features, including:
Director, Center for Innovation in Early Cancer Detection
Director, Massachusetts General Hospital Cancer Center
Chair, Department of Medicine
Chair, Department of Radiology
Chair, Department of Surgery
Chief, Department of Pathology
Chief, Division of Hematology/Oncology
Clinical Director, Massachusetts General Hospital Cancer Center
Investigator, Biostatistics Center
Director, BioMicroElectroMechanical Systems (BioMEMS) Resource Center
Using new and sophisticated tools, experts at Mass General's Pulmonary Nodule Clinic are detecting lung cancers earlier, when they are more curable.
A stroke of luck leaves a lung cancer survivor ready to advance research for early cancer detection.
Meet a group of physician-scientists who are working in the lab and in the clinic to change the ways in which we are able to detect and treat cancer earlier in our patients.
The Pancreatic Cancer Collective is proud to introduce the SU2C-Lustgarten Foundation Pancreatic Cancer Interception Research Team. Pancreatic is probably the most difficult cancer that is treated in the GI tract. Learn what this team is all about and more at PancreaticCancerCollective.org.
One of the problems with lung cancer is that it often gets diagnosed when it’s too late to be cured. This team is finding way to intercept earlier at a time when the cancer is localized. They use a tool called Lung Cancer Interception Assay (LCIA), which determines if a freckle on the lung is actually cancerous or just a harmless freckle. Learn more about this team at StandUpToCancer.org.
Philanthropic support is critical to realizing our vision of a technological revolution that could significantly decrease the burden of cancer on our society.
To learn more about how you can support the Center for Innovation in Early Cancer Detection, please contact Bob O’Brien in the Mass General Development Office at (617) 726-0991 or firstname.lastname@example.org.
Back to Top